ALBIO.PA Stock - Biosynex S.A.
Unlock GoAI Insights for ALBIO.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $101.20M | $92.98M | $196.59M | $382.53M | $153.90M |
| Gross Profit | $-20,000,000 | $49.13M | $64.52M | $182.55M | $48.10M |
| Gross Margin | -19.8% | 52.8% | 32.8% | 47.7% | 31.3% |
| Operating Income | $-21,100,000 | $-37,404,000 | $38.86M | $140.65M | $45.73M |
| Net Income | $-43,300,000 | $-36,946,000 | $15.66M | $104.00M | $31.37M |
| Net Margin | -42.8% | -39.7% | 8.0% | 27.2% | 20.4% |
| EPS | $-3.32 | $-2.85 | $1.26 | $8.32 | $3.43 |
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Visit WebsiteEarnings History & Surprises
ALBIO.PAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Apr 23, 2025 | — | $-1.72 | — | — |
Q3 2024 | Jul 18, 2024 | — | $-1.94 | — | — |
Q2 2024 | May 27, 2024 | — | $-1.54 | — | — |
Q4 2023 | Oct 19, 2023 | — | $-1.89 | — | — |
Q2 2023 | Apr 20, 2023 | — | $-1.45 | — | — |
Q2 2022 | Jun 30, 2022 | — | $2.97 | — | — |
Q4 2021 | Dec 31, 2021 | — | $3.11 | — | — |
Q2 2021 | Jun 30, 2021 | — | $6.84 | — | — |
Q4 2020 | Dec 31, 2020 | — | $2.40 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.65 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.06 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.07 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.04 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.02 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.07 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.12 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.01 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.00 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.13 | — | — |
Q2 2015 | Jun 30, 2015 | — | $0.10 | — | — |
Latest News
Frequently Asked Questions about ALBIO.PA
What is ALBIO.PA's current stock price?
What is the analyst price target for ALBIO.PA?
What sector is Biosynex S.A. in?
What is ALBIO.PA's market cap?
Does ALBIO.PA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ALBIO.PA for comparison